Literature DB >> 2553315

Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.

D A Wulfrank1, K H Schelstraete, F Small, C J Fallais.   

Abstract

Sixty patients with a variety of malignant tumors were examined with Tc-99m(V) dimercaptosuccinic acid (DMSA) prepared by modification of a commercially available DMSA kit. Significant uptake of Tc-99m(V)-DMSA was observed in a number of tumors, offering additional clinically useful information. In the majority of cases in this study, however, the benefit of the Tc-99m(V)-DMSA image was limited because of low sensitivity. The most striking observation was the similarity between the tumor concentration of Tc-99m(V)-DMSA and the Tc-99m-MDP uptake in the tumor on the regular bone image. Therefore, patients with Tc-99m-MDP uptake in nonosseous tumor sites on the bone scan may be suitable candidates for tumor imaging with Tc-99m(V)-DMSA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553315     DOI: 10.1097/00003072-198908000-00007

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  9 in total

1.  Positive imaging of cardiomyopathy with 99mTc(V)-DMSA.

Authors:  H Ohta; T Komibuchi; S Kawamata; K Yamamoto; M Shichirousako; T Wada; H Kotoura; K Shizuki; K Endo; J Konishi
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

2.  Evidence that 99mTc-(V)-DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines.

Authors:  Delphine Denoyer; Nathalie Perek; Nathalie Le Jeune; Delphine Frere; Francis Dubois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-14       Impact factor: 9.236

3.  Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs.

Authors:  C H Kao; S J Wang; S P Wey; L H Shen; G Ting; S H Yeh
Journal:  Eur J Nucl Med       Date:  1992

4.  Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma.

Authors:  Rafał Czepczyński; Maria Gemma Parisella; Jerzy Kosowicz; Renata Mikołajczak; Katarzyna Ziemnicka; Maria Gryczyńska; Jerzy Sowiński; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-26       Impact factor: 9.236

5.  Pitfalls in scintigraphic detection of neuroendocrine tumours.

Authors:  L Feggi; E Degli Uberti; G C Pansini; G Transforini; N Prandini; M R Ambrosio; A R D'Urso; R Faggioli
Journal:  Eur J Nucl Med       Date:  1992

6.  Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.

Authors:  Vassilios J Papantoniou; Michael A Souvatzoglou; Varvara J Valotassiou; Androniki N Louvrou; Constantina Ambela; John Koutsikos; Dimitrios Lazaris; Julie K Christodoulidou; Maria G Sotiropoulou; Maria J Melissinou; Aris Perperoglou; Spyridon Tsiouris; Cherry J Zerva
Journal:  Breast Cancer Res       Date:  2003-12-11       Impact factor: 6.466

7.  Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.

Authors:  Vassilios Papantoniou; Spyridon Tsiouris; Ekaterini Mainta; Varvara Valotassiou; Michael Souvatzoglou; Maria Sotiropoulou; Lydia Nakopoulou; Dimitrios Lazaris; Androniki Louvrou; Maria Melissinou; Artemis Tzannetaki; Ioannis Pirmettis; John Koutsikos; Cherry Zerva
Journal:  Breast Cancer Res       Date:  2004-11-08       Impact factor: 6.466

8.  Role of 99mTc-(V)DMSA in detecting tumor cell proliferation.

Authors:  Fatma Al-Saeedi
Journal:  Anal Chem Insights       Date:  2007-12-13

Review 9.  Dimercaptosuccinic acid: A multifunctional cost effective agent for imaging and therapy.

Authors:  Jaya Shukla; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2015 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.